Kymera Therapeutics Inc. monthly returns
Kymera Therapeutics Inc. has averaged 3.14% per month, positive in 46% of months. Month-by-month returns for Kymera Therapeutics Inc. (KYMR) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Kymera Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -6.3% | |
| Sep 2026 | -5.9% | |
| Aug 2026 | +14.9% | |
| Jul 2026 | -9.8% | |
| Jun 2026 | +40.8% | |
| May 2026 | +0.4% | |
| Apr 2026 | -2.7% | |
| Mar 2026 | -8.8% | |
| Feb 2026 | +25.7% | |
| Jan 2026 | -6.6% | |
| Dec 2025 | +14.6% | |
| Nov 2025 | +9.8% | |
| Oct 2025 | +9.3% | |
| Sep 2025 | +37.4% | |
| Aug 2025 | -5.8% | |
| Jul 2025 | +0.3% | |
| Jun 2025 | +47.2% | |
| May 2025 | -13.5% | |
| Apr 2025 | +25.2% | |
| Mar 2025 | -12.7% | |
| Feb 2025 | -20.8% | |
| Jan 2025 | -1.6% | |
| Dec 2024 | -14.1% | |
| Nov 2024 | +1.5% | |
| Oct 2024 | -2.5% | |
| Sep 2024 | -2.1% | |
| Aug 2024 | +4.7% | |
| Jul 2024 | +54.8% | |
| Jun 2024 | -7.0% | |
| May 2024 | -4.5% | |
| Apr 2024 | -16.4% | |
| Mar 2024 | -5.9% | |
| Feb 2024 | +30.3% | |
| Jan 2024 | +28.8% | |
| Dec 2023 | +22.6% | |
| Nov 2023 | +77.9% | |
| Oct 2023 | -16.0% | |
| Sep 2023 | -27.1% | |
| Aug 2023 | -12.8% | |
| Jul 2023 | -4.8% | |
| Jun 2023 | -21.9% | |
| May 2023 | -6.7% | |
| Apr 2023 | +6.4% | |
| Mar 2023 | -5.6% | |
| Feb 2023 | -16.1% | |
| Jan 2023 | +49.8% | |
| Dec 2022 | -13.9% | |
| Nov 2022 | -4.5% | |
| Oct 2022 | +39.4% | |
| Sep 2022 | -23.0% | |
| Aug 2022 | +28.3% | |
| Jul 2022 | +11.9% | |
| Jun 2022 | +38.0% | |
| May 2022 | -54.5% | |
| Apr 2022 | -25.9% | |
| Mar 2022 | +6.4% | |
| Feb 2022 | -5.3% | |
| Jan 2022 | -33.8% | |
| Dec 2021 | +14.4% | |
| Nov 2021 | -5.7% | |
| Oct 2021 | +0.2% | |
| Sep 2021 | -5.5% | |
| Aug 2021 | +3.3% | |
| Jul 2021 | +24.1% | |
| Jun 2021 | +0.9% | |
| May 2021 | +5.6% | |
| Apr 2021 | +17.2% | |
| Mar 2021 | -19.0% | |
| Feb 2021 | -22.6% | |
| Jan 2021 | -0.1% | |
| Dec 2020 | +32.9% | |
| Nov 2020 | +29.6% | |
| Oct 2020 | +11.4% | |
| Sep 2020 | +1.3% |
Monthly total return (since Nov 2021)#
Kymera Therapeutics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -6.27% — 5th of 6 Octobers since 2021 at the last close; the average October returned +6.1%.
| Month | −80%0+80% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +6.1% | -0.8% | 33% | +49.8% 2023 | -33.8% 2022 | |
| Feb | -1.5% | -10.7% | 33% | +30.3% 2024 | -22.6% 2021 | |
| Mar | -7.6% | -7.3% | 17% | +6.4% 2022 | -19.0% 2021 | |
| Apr | +0.7% | +1.9% | 50% | +25.2% 2025 | -25.9% 2022 | |
| May | -12.2% | -5.6% | 33% | +5.6% 2021 | -54.5% 2022 | |
| Jun | +16.3% | +19.4% | 67% | +47.2% 2025 | -21.9% 2023 | |
| Jul | +12.7% | +6.1% | 67% | +54.8% 2024 | -9.8% 2026 | |
| Aug | +5.4% | +4.0% | 67% | +28.3% 2022 | -12.8% 2023 | |
| Sep | -4.4% | -5.7% | 17% | +37.4% 2025 | -27.1% 2023 | |
| Oct | +6.1% | +0.2% | 60% | +39.4% 2022 | -16.0% 2023 | |
| Nov | +15.8% | +1.5% | 60% | +77.9% 2023 | -5.7% 2021 | |
| Dec | +4.7% | +14.4% | 60% | +22.6% 2023 | -14.1% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from KYMR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Kymera Therapeutics Inc.'s average monthly return?
- Kymera Therapeutics Inc. (KYMR) has averaged about 3.14% per month, positive in roughly 46% of months. The best month was Nov 2023 (+77.9%) and the worst was May 2022 (-54.5%).